Good Life Advisors’s Clorox CLX Stock Holding History

Good Life Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,080	Closed	-$339K	–	507
2024 Q3	$339K	Buy	+2,080	New	+$308K	0.02%	432
2021 Q2	–	Sell	-1,077	Closed	-$207K	–	321
2021 Q1	$207K	Buy	1,077 +15	+1%	+$2.89K	0.04%	289
2020 Q4	$212K	Buy	+1,062	New	+$220K	0.05%	242

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Good Life Advisors's CLX Position: Q4 2024 in Review

Good Life Advisors sold out of Clorox (CLX) in Q4 2024, closing a stake of 2,080 shares — an estimated $339K sold.

Good Life Advisors first reported a position in CLX in Q4 2020 and held it in 3 quarters. The position peaked at $339K in Q3 2024. 1,222 funds tracked by Wall St. Rank hold CLX as of Q4 2024.

Good Life Advisors reported no remaining Clorox position as of Q4 2024 after selling out during the quarter.
Good Life Advisors sold 2,080 Clorox shares in Q4 2024, an estimated $339K.
Good Life Advisors first reported a position in Clorox in Q4 2020 and held it in 3 quarters.
Good Life Advisors's Clorox position peaked at $339K in Q3 2024.
1,222 funds tracked by Wall St. Rank held Clorox as of Q4 2024.

Based on Good Life Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.